VENOUS-TO-VENOUS LOCO-REGIONAL DELIVERY OF A THERAPEUTIC AGENT
20200069925 ยท 2020-03-05
Inventors
Cpc classification
A61M2025/0006
HUMAN NECESSITIES
A61M2025/0031
HUMAN NECESSITIES
A61M1/85
HUMAN NECESSITIES
A61M2025/105
HUMAN NECESSITIES
A61M25/003
HUMAN NECESSITIES
A61M25/0026
HUMAN NECESSITIES
A61M2025/1015
HUMAN NECESSITIES
A61M2025/0681
HUMAN NECESSITIES
International classification
A61M1/00
HUMAN NECESSITIES
A61M5/00
HUMAN NECESSITIES
Abstract
The methods, systems, and devices disclosed herein generally involve a venous-to-venous delivery of drugs to a targeted region within a patient. A triple lumen catheter device is disclosed that is particularly suitable for delivery of therapeutic drugs via a closed loop, preventing the circulation of toxic agents throughout the body, thereby creating an isolated treatment zone that maximizes local therapeutic concentrations while preventing agents from escaping to the rest of the body.
Claims
1. A system for venous-to-venous closed-loop delivery of a therapeutic agent, said method comprising: a triple lumen catheter for delivering said therapeutic agent, wherein said triple lumen catheter further comprises a distal balloon catheter for infusion; and a central sheath for monitoring pressures; and a proximal balloon catheter for aspiration.
2. The system of claim 1, wherein the infusion catheter is in connection with the distal balloon.
3. The system of claim 1, wherein the proximal balloon suctions unused drug out of the body.
4. The system of claim 1, further comprising a transducer to control flow rates and pressures.
5. A method of venous-to-venous closed-loop delivery of a therapeutic agent, the method comprising: positioning a triple lumen catheter into but not limited to a major hepatic vein; targeting treatment through a closed loop delivery; and inserting a specified amount of drug and retrieving unused drug.
6. The method of claim 5, further comprising delivering via a major vein and retrieving unused drug through same major vein.
7. The method of claim 5, further comprising monitoring flow rates and pressures of infused drug.
8. The method of claim 5, further comprising minimizing toxicity level by retrieval of unused drug.
Description
BRIEF DESCRIPTION OF THE DRAWING
[0008] The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
[0009] The aforementioned features and advantages of the disclosed technology as well as additional features and advantages thereof will be more clearly understood hereinafter as a result of a detailed description of preferred implementations when taken in conjunction with the drawings.
[0010]
[0011]
[0012]
[0013]
[0014]
DESCRIPTION OF EXAMPLE EMBODIMENTS
[0015] The disclosed method comprises a venous-to-venous loco-regional delivery of a therapeutic agent using a novel catheter-based delivery system. Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the structure, function, and use of the methods, systems, and devices disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will understand that the methods, systems, and devices specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the present invention is defined solely by the claims.
[0016]
[0017]
[0018]
[0019] With example arrangement illustrated in
[0020] The claimed invention has been depicted and described in detail above with respect to several exemplary embodiments, ordinarily skilled artisans in the relevant fields will readily appreciate that minor changes to the description, and various other modifications, omissions and additions may also be made without departing from either the spirit or scope thereof.